Purification of the fourth, second and fifth components of mouse complement
- PMID: 6698577
- PMCID: PMC1454464
Purification of the fourth, second and fifth components of mouse complement
Abstract
The fourth, second and fifth components of mouse complement were purified by a combination of polyethylene glycol precipitation, ion exchange chromatography and gel filtration. The final products were homogeneous on SDS-PAGE, and the activity yields were 8.5% for C4, 32% for C2 and 40% for C5. C4 was composed of three polypeptide chains with mol. wts of 90,000, 78,000 and 32,000. C2 was composed of a single polypeptide chain with a mol. wt. of 115,000 and cleaved by C1s into two fragments with mol. wts of 80,000 and 35,000. The half life of C4b2a was 7 min and was not prolonged by the iodination of C2. C2 activity could not be measured using EAC14hu or EAC14gp cells, but measurement was possible with the use of EAC14mo cells with purified C5 components of mouse complement. C5 was composed of two polypeptide chains with mol. wts of 135,000 and 84,000. This is the first report on the purification of functionally active mouse complement components C4, C2 and C5 from plasma.
Similar articles
-
Activation of the C4 and C2 components of complement by a proteinase in serum bactericidal factor, Ra reactive factor.J Immunol. 1993 Jan 15;150(2):571-8. J Immunol. 1993. PMID: 8419490
-
Functional and biochemical properties of the early classical complement system of mice.J Immunol. 1978 Jan;120(1):216-24. J Immunol. 1978. PMID: 627718
-
Fifth component of guinea pig complement: purification and characterization.J Immunol. 1981 Jun;126(6):2414-8. J Immunol. 1981. PMID: 7229382
-
The purification and properties of the second component of human complement.Biochem J. 1978 Apr 1;171(1):99-107. doi: 10.1042/bj1710099. Biochem J. 1978. PMID: 417728 Free PMC article.
-
[The second component of complement, C2].Nihon Rinsho. 1999 Nov;57 Suppl:44-6. Nihon Rinsho. 1999. PMID: 10635770 Review. Japanese. No abstract available.
Cited by
-
Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement research.J Clin Invest. 2025 Jun 16;135(12):e188347. doi: 10.1172/JCI188347. eCollection 2025 Jun 16. J Clin Invest. 2025. PMID: 40519165 Free PMC article. Review.
-
Experimental lupus nephritis in severe combined immunodeficient (SCID) mice: remodelling of the glomerular lesions by bystander IgM antibodies.Clin Exp Immunol. 2000 Feb;119(2):340-5. doi: 10.1046/j.1365-2249.2000.01133.x. Clin Exp Immunol. 2000. PMID: 10632673 Free PMC article.
-
Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases.BMC Immunol. 2010 Aug 20;11:43. doi: 10.1186/1471-2172-11-43. BMC Immunol. 2010. PMID: 20727163 Free PMC article.
-
Structural polymorphism of mouse complement C2 detected by microscale peptide mapping: linkage to H-2.Immunogenetics. 1984;19(6):493-501. doi: 10.1007/BF00403440. Immunogenetics. 1984. PMID: 6735447
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous